US Bancorp’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.91K | Buy |
1,596
+182
| +13% | +$446 | ﹤0.01% | 3704 |
|
|
2025
Q1 | $9.43K | Sell |
1,414
-58
| -4% | -$387 | ﹤0.01% | 3443 |
|
|
2024
Q4 | $18.5K | Buy |
1,472
+620
| +73% | +$7.79K | ﹤0.01% | 3184 |
|
|
2024
Q3 | $15.7K | Sell |
852
-230
| -21% | -$4.25K | ﹤0.01% | 3206 |
|
|
2024
Q2 | $23.3K | Sell |
1,082
-1,095
| -50% | -$23.6K | ﹤0.01% | 2997 |
|
|
2024
Q1 | $58.6K | Sell |
2,177
-4,190
| -66% | -$113K | ﹤0.01% | 2604 |
|
|
2023
Q4 | $191K | Sell |
6,367
-3,194
| -33% | -$95.7K | ﹤0.01% | 2028 |
|
|
2023
Q3 | $196K | Buy |
9,561
+8,230
| +618% | +$169K | ﹤0.01% | 1840 |
|
|
2023
Q2 | $26.4K | Buy |
1,331
+113
| +9% | +$2.25K | ﹤0.01% | 2811 |
|
|
2023
Q1 | $20.9K | Buy |
1,218
+30
| +3% | +$514 | ﹤0.01% | 2954 |
|
|
2022
Q4 | $23.2K | Sell |
1,188
-91
| -7% | -$1.78K | ﹤0.01% | 2911 |
|
|
2022
Q3 | $20K | Sell |
1,279
-346
| -21% | -$5.41K | ﹤0.01% | 3007 |
|
|
2022
Q2 | $22K | Sell |
1,625
-8,659
| -84% | -$117K | ﹤0.01% | 2991 |
|
|
2022
Q1 | $164K | Buy |
10,284
+1,150
| +13% | +$18.3K | ﹤0.01% | 2038 |
|
|
2021
Q4 | $199K | Buy |
9,134
+1,344
| +17% | +$29.3K | ﹤0.01% | 1975 |
|
|
2021
Q3 | $233K | Buy |
7,790
+1,902
| +32% | +$56.9K | ﹤0.01% | 1901 |
|
|
2021
Q2 | $261K | Buy |
5,888
+811
| +16% | +$36K | ﹤0.01% | 1861 |
|
|
2021
Q1 | $225K | Buy |
5,077
+4,822
| +1,891% | +$214K | ﹤0.01% | 1870 |
|
|
2020
Q4 | $14K | Buy |
255
+142
| +126% | +$7.8K | ﹤0.01% | 3041 |
|
|
2020
Q3 | $3K | Buy |
+113
| New | +$3K | ﹤0.01% | 3368 |
|